Top Markets
Coin of the day
Gentian Diagnostics AS Gentian Diagnostics AS

Gentian Diagnostics AS

GENT
Rank in Stocks #24261
Gentian Diagnostics ASA develops, manufactures, and sells biochemical reagents... Gentian Diagnostics ASA develops, manufactures, and sells biochemical reagents for use in medical diagnostics and research in the United States, Asia, and Europe. It offers in-vitro diagnostic reagents for clinical chemistry analyzers, such as Gentian Calprotectin Immunoassay, a turbidimetric assay used for the measurement of circulating calprotectin in plasma and serum for detection and assessment of inflammation; Gentian Cystatin C Immunoassay test kit, a GFR marker for the diagnosis and therapeutic control of renal function and chronic kidney disease; Gentian Retinol-Binding Protein Immunoassay for detection of retinol-binding protein in human serum and plasma; and Canine CRP Immunoassay test kit, a particle-enhanced turbidimetric immunoassay for quantitative determination of canine C-reactive protein in dog plasma and serum. The company also develops faecal calprotectin immunoassay turbo that offers results of calprotectin concentration in stool supporting diagnosis of inflammatory bowel disease; and faecal pancreatic elastase immunoassay turbo, which allows analysis of pancreatic elastase in stool to aid in diagnosis of pancreatic exocrine insufficiency. Gentian Diagnostics ASA was founded in 2001 and is headquartered in Moss, Norway.
Share Price
$4.07
Last synced: 2026-08-21
Market Cap
$62.87M
Change (1 day)
3.19%
Change (1 year)
-28.25%
Country
NO
Trade Gentian Diagnostics AS (GENT)

Category

Price of GENT with the market cap of B
Gentian Diagnostics AS Gentian Diagnostics AS
GENT
$4.07
Market Capitalization of Gentian Diagnostics AS(GENT)
Market Cap: $62.87M
As of August 2026 Gentian Diagnostics AS has a market cap of $62.87M. This makes Gentian Diagnostics AS the world's 24261st most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Market cap history of Gentian Diagnostics AS from 2016 to 2026
GENT compared with Top 5 Most Popular stocks
Price of GENT Asset B Mkt. of B Results
Gentian Diagnostics AS Gentian Diagnostics AS
$337,119 $62.87M
$5.211T +8,289,352.54%
Gentian Diagnostics AS Gentian Diagnostics AS
$294,125 $62.87M
$4.547T +7,232,171.57%
Gentian Diagnostics AS Gentian Diagnostics AS
$269,267 $62.87M
$4.162T +6,620,933.30%
Gentian Diagnostics AS Gentian Diagnostics AS
$232,414 $62.87M
$3.593T +5,714,764.72%
Gentian Diagnostics AS Gentian Diagnostics AS
$180,667 $62.87M
$2.793T +4,442,347.62%